Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
Clinical trial NCT05550246 · UNKNOWN
Trial details
- NCT number
- NCT05550246
- Sponsor
- Brigham and Women's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2024-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.